State Street SPDR S&P Biotech ETF XBI

State Street SPDR S&P Biotech ETF (XBI) is newly tracked — analyst coverage is still building.

1 YouTube analyst covers State Street SPDR S&P Biotech ETF (XBI).

1 analyst has covered XBI so far…

Analyst opinions

T3 Live1d ago

BEAR$XBISwingTechnical

extended move after multi-year consolidation.

XBI is currently extended after a multi-year consolidation, making it more of a sell than a buy at current levels.

The ETF has broken out of a multi-year consolidation, but the current extension suggests the move may be overextended. It is likely a better candidate for selling than buying at this stage.

"Scott Redler’s #630club - LIVE Premarket Stock Market Update"

T3 Live9d ago

BULL$XBISwingTechnical

long at 133 with summer seasonality.

XBI looks good above moving averages; long at 133 could work with summer seasonality.

Biotech index XBI is above moving averages and tightening. Last time it tightened, it had a sharp move. Long at 133 benefits from historical summer strength.

"Scott Redler’s #630club - LIVE Premarket Stock Market Update"

No official filings surfaced for XBI yet.